Moderator: Donna D. Ohnmeiss, PhD
97. The effect of physical therapy on time to discharge after lumbar interbody fusion
Mohamed Macki, MD1; Hesham M. Zakaria, MD1; Lara W. Massie, MD1; Belal Dakroub2; Victor Chang, MD3
1Henry Ford Hospital, Detroit, MI, US; 2North Chicago, IL, US; 3Henry Ford West Bloomfield Hospital, West Bloomfield, MI, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
98. Differences in functional treadmill tests in patients with adult symptomatic lumbar scoliosis treated operatively and non-operatively
Jamal Shillingford, MD; Steven D. Glassman, MD1; Leah Y. Carreon, MD, MSc1; Elizabeth Yanik, PhD, MSc2; Michael P. Kelly, MD3; Jon D. Lurie, MD4; Keith H. Bridwell, MD5
1Norton Leatherman Spine Center, Louisville, KY, US; 2Washington University in St. Louis, St. Louis, MO, US; 3Washington University, Saint Louis, MO, US; 4Dartmouth College, Lebanon, NH, US; 5Washington University In St. Louis School of Medicine, Saint Louis, MO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
99. Gait analysis provides an objective measure of functional deficit not adequately assessed by oswestry disability index
Ram Haddas, PhD, MSc, MEng1; Akwasi Boah, MD2; Isador H. Lieberman, MD, FRCSC, MBA3; Andrew R. Block, PhD1
1Texas Back Institute, Plano, TX, US; 2Texas Back Institute - Denton, Denton, TX, US; 3Scoliosis and Spine Tumor Center, Texas Back Institute, Texas Health Presbyterian Hospital Plano, Plano, TX, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
100. The Dubousset Functional Test: A baseline analysis of a novel, multi-domain assessment of physical function and balance
Bassel G. Diebo, MD1; Vincent Challier, MD2; Neil V. Shah, MD, MS3; David Kim, BS3; Barthelemy Liabaud, MD4; Renaud Lafage, MSc5; Carl B. Paulino, MD3; Peter G. Passias, MD6; Frank J. Schwab, MD5; Virginie Lafage, PhD5
1Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 2Spine Unit, Clinique Francheville, Perigueux, France; 3SUNY Downstate Medical Center, Brooklyn, NY, US; 4SUNY Downstate, Brooklyn, NY, US; 5Hospital for Special Surgery, New York, NY, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
101. Improvement in multiple domains of functional status with Increasing physical activity after lumbar surgery: longitudinal analysis
Carol A. Mancuso, MD; Manuela Rigaud, MS; Roland Duculan, MD; Frank P. Cammisa, MD; Andrew A. Sama, MD; Alexander P. Hughes, MD; Darren R. Lebl, MD; Russel C. Huang, MD; Harvinder S. Sandhu, MD; Federico P. Girardi, MD
Hospital for Special Surgery, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
102. Accuracy of physical examination on ruling out CES: is MRI necessary?
Natalie L. Zusman, MD1; Stephanie S. Radoslovich, BA1; Spencer J. Smith1; Kenneth R. Gundle, MD2; Jung U. Yoo, MD1
1Oregon Health and Science University, Portland, OR, US; 2OHSU Dept. of Orthopaedics, Portland, OR, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
103. Factors associated with motor, sensory, bladder and bowel function recovery after traumatic cauda equina injury (TCEI)
Najmedden Attabib, FRCSC1; Colleen O'Connell, MD, FRCP2; Dilnur Kurban, MSc3; Carly S. Rivers, PhD, MSc, BS4; Vanessa K. Noonan, PhD4; Karen Ethans, MD, FRCP5; Heather Flett, MSc, PT6; Christopher S. Bailey, MD, FRCSC7; Sean D. Christie, MD8; Eve C. Tsai, MD, PhD, FRCSC9; Julio C. Furlan, MD, PhD10
1Saint John, NB, Canada; 2Stan Cassidy Centre for Rehabilitation, Fredericton, NB, Canada; 3Vancouver, BC, Canada; 4Rick Hansen Institute, Vancouver, BC, Canada; 5University of Manitoba/HSC, Winnipeg, MB, Canada; 6University Health Network, Toronto, ON, Canada; 7U of Western Ontario/London Health Sciences Centre, London, ON, Canada; 8QE II Health Sciences Centre, Halifax, NS, Canada; 9C2 Neurosciences Unit, Ottawa, ON, Canada; 10Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion